Brighter deltar med sin diabeteslösning Actiste i en storsatsning på hälsoteknik i Sverige. Projektet syftar till att förbättra förutsättningarna för

Brighter har sedan 2015 fokuserat på utveckling och CE-certifiering av bolagets flaggskeppserbjudande Actiste® Diabetes Management as a Service – en tjänst

We are human innovation. Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We are currently focused on treating diabetes through our solution Actiste, the world’s first unified diabetes care device with a mobile connection. Read more about us. Try out Actiste virtually with our app!

About Brighter AB. Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and our first innovative solution Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter AB (publ): Actiste® Mini receives market approval in the Kingdom of Saudi Arabia. Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini has received market approval from the Saudi Food and Drug Authority (SFDA).Actiste® Mini is a smart and user-friendly blood glucose meter with global out-of-the-box internet connectivity through eSIM, aiming to Brighter Sweden. Norgegatan 2 164 32 Kista, Sweden Phone: +46 (0)8-550 088 20 Fax: +46 (0)8-550 088 30. Brighter UAE. Actiste®, Brighter One™, The diabetes management system Actiste combines a blood glucose meter with a lancet and an injection pen.

Learn more about Actiste: https://actiste.com/Learn more about Brighter: https://www.brighter.se/ Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Wssonlines Nigeria Ltd i Nigeria ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten”).

Köp aktien Brighter AB (BRIG). Hos Nordnet kan du Brighter AB (publ): Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten. 2021-03-21

Brighter - A human innovation company, Stockholm, Sweden. 4.2K likes · 1 talking about this. Brighter is a group of innovation companies that addresses common public health challenges.

Brighter AB (publ): Brighter tecknar 5-årigt avtal och erhåller initial order av Actiste® värd EUR 1,2 miljoner i Ghana. Publicerad: 2020-12-30 (Cision) Brighter AB (publ): Brighter signs 5-year agreement and receives initial order for Actiste® worth EUR 1.2 Million in Ghana

We are broadening our diabetes-care range with the introduction of Actiste Mini – a product and service offering for taking blood samples, measuring blood glucose and monitoring values over time. Actiste Mini is compact, easy to use and has smart compartments for test strips and lancets. Actiste introduces a new level of user friendliness and control in the treatment of diabetes. This app is a companion to the Actiste® device used for insulin treatment and blood glucose measurement. The app gives you the possibility to view blood glucose values and insulin doses, record meals and exercise, and set smart reminders. Brighter’s pioneering diabetes management solution Actiste® receives market approval in the United Arab Emirates Mon, Nov 09, 2020 12:07 CET. Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management, Actiste®, has received market approval from the UAE Ministry of Health and Prevention (“MOHAP”). Brighter has initiated a partnership with The Provincial Government of West Java, Indonesia, and will as part of this deliver 100 Actiste to support diabetes patients in the region.

Styrelsen i Brighter AB (publ) (”Brighter” eller ”Bolaget”) har idag, med stöd av det emissionsbemyndigande som lämnades vid årsstämma den 9 Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Al Danah Medical Company i Qatar ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten"). Både Actiste® och den nyligen utvecklade Actiste® Mini ingår i avtalet. Brighter AB (publ): Actiste® Mini receives market approval in the United Arab Emirates 2021-03-21 18:15 · Cision Brighter AB (publ): Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten Brighter erbjuder nu privatpersoner i Sverige att teckna abonnemang för diabetestjänsten Actiste® ons, maj 20, 2020 08:31 CET Abonnemang kan tecknas direkt via Actiste-hemsidan och leveranser inleds från och med maj 2020. Brighter AB (publ): Brighter inleder nästa fas i marknadsintroduktionen av Actiste i Nigeria och Ghana.

Try out Actiste virtually with our app! If you have our business card, download our app from App Store or Google Play (search for Actiste). Hold the business cards picture side towards the camera to activate an interactive Mixed Reality (MR) demo of Actiste, to show off for astonished friends and colleagues! Actiste ® and The Benefit Loop ® are trademarks of Brighter AB (Publ).
Humanitärt bistånd

ar sjukpenning pensionsgrundande
tomt onsala säljes
hunddagis kalmar södra vägen
hinduismen kvinnosyn
vad är windows tangenten
tilläggstavla som anger utsträckning
ikea slogan

Data-driven solutions for smarter treatment of chronic conditions. Brighter is a health-tech company from Sweden with a vision of a world where managing

Hvad betyder inflation
personalbil vs tjanstebil

Med Actiste® Mini, och den ursprungliga Actiste®-tjänsten designad för insulinbehandlad diabetes, kommer Brighter att kunna rikta sig till

– Godkännandet av vårt huvudpatent innebär att en viktig Data-driven solutions for smarter treatment of chronic conditions.

Den digitala vårdgivaren Accumbo initierar "Diabetesdoktorn” med Brighters diabetestjänst Actiste®. Stockholm, Sverige - Brighter AB (publ.)

Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Al Danah Medical Company i Qatar ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten"). Både Actiste® och den nyligen utvecklade Actiste® Mini ingår i avtalet. Brighter väljer AIS & Ericsson för lansering av diabeteslösningen Actiste i Thailand. tis, maj 16, 2017 08:30 CET. Thailands ledande mobiloperatör AIS blir tillsammans med Ericsson Brighters partner i lanseringen av Actiste på den thailändska marknaden. Brighter has initiated a partnership with The Provincial Government of West Java, Indonesia, and will as part of this deliver 100 Actiste to support diabetes patients in the region.Within the framework of the collaboration, West Java and Brighter will train healthcare staff at local hospitals in administering the service and the data-driven care that Actiste makes possible.

Våra analytiker har över 50 års samlad börserfarenhet. We are human innovation. Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle.